The National Pharmaceutical Pricing Authority (NPPA) notified Trade Margin Rationalisation (TMR) for 137 non-scheduled anti-cancer drugs on 17 October 2026, capping trade margins at 30% of MRP (excluding GST); revised prices apply from 9 November 2026.
The order uses Paragraph 19 of the Drugs (Prices Control) Order, 2013 - issued under the Essential Commodities Act, 1955 - which lets the Centre fix prices in extraordinary circumstances in the public interest.
MRPs are expected to fall by up to 70%; the list, drawn up by an Expert Committee under the DGHS, includes Pembrolizumab, Durvalumab, Osimertinib, Denosumab, Pegfilgrastim and Bevacizumab.
It formalises the in-principle approval at NPPA's 151st meeting on 8 October and widens the 2019 pilot, which covered 42 anti-cancer drugs and cut MRPs of 526 brands by up to 90%.
Parent law; drugs are an essential commodity, and the DPCO is issued under it
Extraordinary power to fix or revise the price of ANY drug, including non-scheduled ones, in public interest - the basis of this cap and of the 2019 pilot
Lists scheduled formulations, drawn from the National List of Essential Medicines, which carry ceiling prices; the 137 drugs here are outside it
Fixes and revises drug prices and enforces the DPCO; set up by Government resolution of 29 August 1997 (not a statutory body); attached office of the Department of Pharmaceuticals
Administrative department for NPPA, under the Ministry of Chemicals and Fertilizers
Technical arm of the Ministry of Health and Family Welfare; its Expert Committee of oncologists and officials selected the 137 drugs
Pilot TMR: 30% cap on 42 non-scheduled anti-cancer drugs under Paragraph 19
NPPA's 151st meeting approves the cap in principle; DGHS committee to finalise the list
Supreme Court asks why the cap stops at cancer drugs; Centre to file modalities by 27 October
Gazette notification for 137 drugs
Revised prices take effect
Instead of fixing one ceiling price, the regulator caps the gap between the price to the retailer and the MRP. Each brand keeps its own MRP, but the mark-up added along the supply chain cannot exceed the cap - here 30% of MRP.
Simple Analogy: Not fixing the shirt's price, only the shop's maximum profit on it.
GS Paper II > Health; GS Paper III > Economy - price regulation
General Awareness > Economy > Government bodies
General Awareness > Regulators and ministries
In India, markets in agricultural products are regulated under the
Answer: Agricultural Produce Market Committee Act enacted by States
A medicine outside Schedule I of the DPCO; normally only its annual price rise is capped (10%), not its price
The difference between the price to the retailer and the MRP
Emergency power to fix the price of any drug in extraordinary circumstances in public interest
National List of Essential Medicines (384 medicines in NLEM 2022); its drugs form Schedule I of the DPCO